Latest filing published 23 Mar 2026 for Cinclus Pharma Holding AB (publ), €10k.
Filing timeline
BuySaleInsider track record
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Jesper Wiklund: trading record in brief
Jesper Wiklund is a declared insider of Cinclus Pharma Holding AB (publ) (board member), with filings sourced from Finansinspektionen. We count 2 filings; the first trade dates from 19 March 2026 and the latest from 20 March 2026.
Every open-market trade on record is a purchase: 2 purchases worth €20k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The latest filing, published on 23 March 2026, reports an open-market purchase of €9,552 in Cinclus Pharma Holding AB (publ). Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Jesper Wiklund
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 6,000 shares@ €1.66820.020% mcap100.0% of flowAktieISIN SE0020388577FI:A003X228-1Canonical exit: 18 Jun 2026 (T+90)
1 of 1 declaration